In the dynamic world of pharmaceutical manufacturing, securing a consistent supply of high-quality intermediates is paramount. For those involved in producing critical antithrombotic agents like Ticagrelor, understanding the nuances of sourcing key building blocks is crucial. One such vital component is 2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tataric acid, identified by its CAS number 376608-65-0.

This intermediate plays an indispensable role in the synthesis of Ticagrelor, a medication widely used to prevent cardiovascular events such as heart attacks and strokes in patients with Acute Coronary Syndrome (ACS). The efficacy and safety of the final drug product are directly influenced by the purity and quality of its intermediates. Therefore, pharmaceutical companies must be discerning when selecting a manufacturer or supplier.

When evaluating potential suppliers for CAS 376608-65-0, several factors should be prioritized. Firstly, the assay purity is critical. A high assay, typically above 98.0% and ideally within the 98.0%~102.0% range as often specified, ensures that the intermediate is robust and will perform reliably in complex synthetic pathways. Secondly, the physical characteristics, such as a white to off-white powder appearance, are indicative of proper manufacturing and handling.

Furthermore, the geographical origin and manufacturing practices of the supplier matter. Manufacturers based in China, for instance, often offer competitive pricing due to economies of scale and established chemical synthesis infrastructure. However, it is essential to partner with reputable suppliers who can provide comprehensive documentation, including Certificates of Analysis (CoA) and Material Safety Data Sheets (MSDS). A reliable manufacturer will also offer consistent production capacity and adhere to stringent quality control measures.

For procurement managers and R&D scientists, understanding the market dynamics for such intermediates is key to cost-effective operations. Inquiring about bulk purchase options and long-term supply agreements can lead to significant price advantages. Exploring options such as direct import from manufacturers or working with established distributors can also streamline the acquisition process. When searching for a supplier, using specific keywords like 'buy ticagrelor intermediate CAS 376608-65-0,' 'ticagrelor intermediate manufacturer in China,' or 'price of 2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tataric acid' will yield relevant results.

In conclusion, sourcing high-quality Ticagrelor intermediate involves a thorough evaluation of purity, supplier reliability, and cost-effectiveness. By focusing on these key aspects and engaging with experienced pharmaceutical chemical manufacturers, companies can ensure a stable supply chain, optimize their production costs, and ultimately contribute to delivering essential cardiovascular medications to patients worldwide.